Thromb Haemost 2008; 100(01): 09-10
DOI: 10.1160/TH08-05-0308
Editorial Focus
Schattauer GmbH

The hidden sepsis marker: aPTT waveform analysis

Carl-Erik Dempfle
1   University Hospital of Mannheim, I. Department of Medicine, Mannheim, Germany
,
Martin Borggrefe
1   University Hospital of Mannheim, I. Department of Medicine, Mannheim, Germany
› Author Affiliations
Further Information

Publication History

Received: 19 May 2008

Accepted: 19 May 2008

Publication Date:
22 November 2017 (online)

 

 
  • References

  • 1 Downey C. et al. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997; 98: 68-73.
  • 2 Downey C. et al. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis. Thromb Haemost 1998; 80: 65-69.
  • 3 Dempfle CE. et al. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod. Blood 2000; 96: 2793-2802.
  • 4 Toh CH. et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002; 100: 2522-2529.
  • 5 Cabana VG. et al. Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein. J Immunol 1982; 128: 2342-2348.
  • 6 Hulman G. et al. Agglutination of intralipid by sera of acutely ill patients. Lancet 1982; 02: 1426-1427.
  • 7 Richter D. et al. The fat emulsion agglutination test: a reliable and cost effective alternative to the latex agglutination test for rapid bedside CRP measurement. Clin Chim Acta 1997; 261: 141-148.
  • 8 Zagara G. et al. C-reactive protein and serum agglutination in vivo of intravenous fat emulsions. Lancet 1989; 01: 733.
  • 9 Rowe IF. et al. Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984; 58: 237-244.
  • 10 Rowe IF. et al. Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. J Exp Med 1984; 159: 604-616.
  • 11 Cabana VG. et al. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39-49.
  • 12 Aspichueta P. et al. Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver. J Lipid Res 2005; 46: 1017-1026.
  • 13 Bennett MJ. et al. Utilization of very low density lipoprotein by rat heart: the effect of endotoxin. Am J Physiol Endocrinol Metab 2000; 278: E802-810.
  • 14 Chopin N. et al. Activated partial thromboplastin time waveform analysis: a new tool to detect infection?. Crit Care Med 2006; 34: 1654-1660.
  • 15 Zakariah AN. et al. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med 2008; 36: 1507-1512.
  • 16 Dempfle CE. et al. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit. Crit Care Med 2004; 32: 520-524.
  • 17 Toh CH. et al. Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Implications of lipoprotein-complexed C reactive protein formation. Intensive Care Med 2003; 29: 55-61.
  • 18 Bakhtiari K. et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-2421.
  • 19 Smith EY. et al. Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol 2004; 121: 138-141.
  • 20 Hussain N. et al. The BiphasicTransmittance Wave-form: An early maker of sepsis in patients with neutropenia. Thromb Haemost 2008; 100: 146-148.
  • 21 Matsumoto T. et al. Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation. Clin Appl Thromb Hemost 2006; 12: 185-192.
  • 22 Moyer MP. et al. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vasc Biol 1998; 18: 458-465.
  • 23 Ibrahim S. et al. Transfer of very low density lipoprotein-associated phospholipids to activated human platelets. J Lipid Res 2006; 47: 341-348.
  • 24 Elmas E. et al. Activation of coagulation during alimentary lipemia under real-life conditions. Int J Cardiol 2007; 114: 172-175.
  • 25 Kjalke M. et al. Plasma lipoproteins enhance tissue factor-independent factor VII activation. Arterioscler Thromb Vasc Biol 2000; 20: 1835-1841.
  • 26 Klein S. et al. Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteins. Arterioscler Thromb Vasc Biol 2001; 21: 1695-1700.
  • 27 Rota S. et al. Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood 1998; 91: 508-515.